Premium
Low‐Molecular‐Weight Heparins for Acute Coronary Syndromes: An Emergency Medicine Perspective
Author(s) -
Gonzalez Edgar R.
Publication year - 1999
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1592/phco.19.14.155s.31704
Subject(s) - medicine , emergency department , myocardial infarction , unstable angina , chest pain , perspective (graphical) , angina , intensive care medicine , heparin , cardiology , psychiatry , artificial intelligence , computer science
Patients with chest pain represent one of the largest and most challenging populations for emergency departments to treat. Diagnostic and treatment modalities implemented in the emergency department are associated with significant clinical outcomes and financial implications. Critical pathways are being developed to increase the speed and efficiency with which these patients are managed. Of particular importance is the evolving role of low‐molecular‐weight heparins, which have both clinical and economic advantages over unfractionated heparins in treating unstable angina and non‐Q wave myocardial infarction.